• Journal of Digital Convergence
• /
• v.11 no.9
• /
• pp.255-265
• /
• 2013

The purpose of this study was to identify the variation factors of hypertension medication rate between regions and to use them as a basic data for establishment of hypertension management business plan which is customized by region. The data were collected from community health survey, National Statistics Office and National Health Insurance Corporation, and were analyzed using the geographically weighted regression. As the result of analysis, the factors that influenced the hypertension medication rate between regions were subjective recognition rate of health level, the rate of medical aid client and the number of health facility per one hundred thousand of population. According to the geographically weighted regression, the total of 230 regional regression models composed of major variables which affected the hypertension medication rate were calculated. However, this study has several limitations that the explanatory power of model is not high and others. Therefore, a follow-up study which is based on the actual data of compliance with hypertension medication will be necessary.

• Proceedings of the PSK Conference
• /
• 2005.04a
• /
• pp.137-139
• /
• 2005

• Korean Journal of Clinical Pharmacy
• /
• v.32 no.2
• /
• pp.116-124
• /
• 2022

Background: High-alert medications (HAMs) are medications that bear a heightened risk of causing significant patient harm if used in error. To facilitate safe use of HAMs, identifying specific HAM lists for clinical setting is necessary. We aimed to develop the national level HAM list for acute care setting. Methods: We used three-step process. First, we compiled the pre-existing lists referring HAMs. Second, we analyzed medication related incidents reported from national patient safety incident report data and adverse events indicating medication errors from the Korea Adverse Event Reporting System (KAERS). We also surveyed the assistant staffs to support patient safety tasks and pharmacist in charge of medication safety in acute care hospital. From findings from analysis and survey results we created additional candidate list of HAMs. Third, we derived the final list for HAMs in acute care settings through expert panel surveys. Results: From pre-existing HAM list, preliminary list consisting of 42 medication class/ingredients was derived. Eight assistant staff to support patient safety tasks and 39 pharmacists in charge of medication safety responded to the survey. Additional 44 medication were listed from national patient safety incident report data, KAERS data and common medications involved in prescribing errors and dispensing errors from survey data. A list of mandatory and optional HAMs consisting of 10 and 6 medication classes, respectively, was developed by consensus of the expert group. Conclusion: We developed national level HAM list for Korean acute care setting from pre-existing lists, analyzing medication error data, survey and expert panel consensus.

• Proceedings of the PSK Conference
• /
• 2003.10b
• /
• pp.71.2-72
• /
• 2003

This presentation is to enhance the pharmacist's role in Over-The-Counter(OTC) drug selection and patient counseling for diversification of pharmacy management after the separation of prescribing and dispensing practice in Korea. Self-medication by OTC drugs may be viewed as one element of the broader self-care treatment. The patient may use a OTC drug to manage a minor ailment, a process that may be supported by counseling from a pharmacist. Pharmacists involved in self-medication decisions have a greater involvement with patients and an enhanced professional role. (omitted)

• Proceedings of the PSK Conference
• /
• 2003.10b
• /
• pp.72.1-72.1
• /
• 2003

The use of auxiliary labels in many advanced countries has shown that patients and caregivers understanding, safety and compliance with proper administration of medication is significantly increased. Although in Korea we give required information orally and written on the packaging when we dispense medication, many international studies have demonstrated a marked increase in full compliance when auxiliary labels were used. The pharmacist must insure that the patients understand how to take correctly in order to get the maximum effect of treatment. (omitted)

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.32 no.5
• /
• pp.299-304
• /
• 2018

The aim of this study to distinguish Yin-Deficiency and Blood-Deficiency in Donguibogam To Investigate the Donguibogam Hu-Ro Sector "Yin-Deficiency Medication" and other parts and associating Herb(Bencao) In Donguibogam Hu-Ro Sector "Yin-Deficiency Medication", Yin-Deficiency is divided Blood-Deficiency and Em Hu Hwa Dong. But Si Wu Tang treating Blood-Deficiency be used at Em Hu Hwa Dong and Da Bu Yin Wan treating Em Hu Hwa Dong be used at Blood-Deficiency. But in the use of each Herb(Bencao), Yin-Deficiency Medicine and Blood-Deficiency Medicine are distinguised. One can understand that Donguibogam's use of prescription might not distinguish Yin-Deficiency and Blood-Deficiency, But each Herb(Bencao) distinguish those conceptions. Because each view is both meaningful, choosing of view in accordance with the purpose of treatment is necessary for successful clinical trial.

• Asian Pacific Journal of Cancer Prevention
• /
• v.16 no.14
• /
• pp.6055-6059
• /
• 2015

Background: Medication policy development in Thailand is continually promoting rational drug use. Letrozole, an endocrine therapy drug, is usually prescribed for post-menopausal status early and advanced stage breast cancer. After Ministry of Public Health announced Letrozole as compulsory licensed drug in 2009, more breast cancer patients can access to this drug at low cost especially those within universal coverage schemes. To ensure that Letrozole is rationally prescribed, the drug utilization study was conducted. Objectives: The aim of this study was to describe the appropriate use of Letrozole in breast cancer and the relationship between appropriate use and health benefit schemes. Materials and Methods: A retrospective study to evaluate use of Letrozole in breast cancer patients was performed for six months between January - June 2010 in seven regional cancer hospitals, Thailand. All prescriptions of Letrozole were identified from pharmacy dispensing databases and prescription papers. A medical record review was also performed to evaluate appropriate use referring to the drug use evaluation criteria. The approved criterion of this study was referred from the guideline of Thai National Formulary version 2010. Results: There were 681 prescriptions of Letrozole for 254 breast cancer patients with an average age of $58.6{\pm}10.0years$. The patients in universal coverage scheme (UCS), civil servant medication benefit scheme (CSMBS) and social security scheme (SSS) were 77.7%, 18.5% and 8.7% respectively. 10.6% were prescribed Letrozole for the first time. Letrozole were prescribed by oncologists (82.8%). The average number of tablets per prescription was $58{\pm}10$. Calcium supplements were prescribed concomitant with Letrozole for 19.4%. To assess drug use evaluation criteria, 45 prescriptions were excluded because of uncompleted clinical data, 636 prescriptions were evaluated. The study showed 86 prescriptions (13.5%) with inappropriate use including 6 (0.9%) not prescribed for estrogen receptor (ER) and/or progesterone receptor (PR) positive, 31 (4.9%) not prescribed for post-menopausal and 49 (7.7%) not prescribed for an appropriate duration. Appropriate use percentages in different health benefit schemes were similar, 85.7% of CSMBS, 86.4% of SSS and 86.7% of UCS. The relationship between health benefit scheme and appropriate use of Letrozole was not significantly different, ${\chi}^2$ (2, N = 636) = 0.081, p > 0.05. Conclusions: The study showed inappropriate use in breast cancer patients because of non-compliance with duration, menopausal status and hormone receptor requirements. To prescribe appropriate indication did not referred to the appropriate practice along the treatment. Drug use evaluation proved very useful for detecting the sign of inappropriate use and allows immediate feedback to the stakeholder for developing medication policy in the future. Importantly, there was no significantly difference in appropriate use of Letrozole across health benefit schemes.

• Korean Journal of Clinical Pharmacy
• /
• v.30 no.3
• /
• pp.185-195
• /
• 2020

Objective: This study aimed to explore a veteran patients' behavior of prescribing drug use and of which influencing factors from the veteran patients' perspective through qualitative interviews. Methods: We recruited veteran patients through purposive sampling and interviewed 30 veteran patients aged 20 and over who had been taking prescription drugs. We developed and utilized an interview guide consisting of three themes for data collection. We made verbatim transcripts and analyzed data using the framework analysis. Results: Participants were aware that they had large amounts of prescribing medicines and discarded the medicines. They often used improperly by the person himself or his family or acquaintances. The factors that influenced these inefficient prescription drug usage were grouped into 'factors procuring more drugs than necessary' and 'factors being prescribed more drugs than necessary'. Anxiety about downgrading from the upper class to the lower among reward classes for veterans, and suspicion or dissatisfaction with the veteran policy caused the participants to procure more drugs than necessary. Additionally, they received too many medicines due to long-term prescriptions and lack of communication with their doctors, and poor quality of veteran health services. Conclusion: To improve the medication use behavior of veteran patients, providing information or introducing interventions for the proper medication use is not enough. Efforts should be made to improve their negative recognition over relevant policies and health care services.

• The Journal of Korean Medicine
• /
• v.25 no.1
• /
• pp.142-151
• /
• 2004

Objectives : To document the use and out-of-pocket expenditure of complementary and alternative medicine(CAM) in Korean adult population. Methods : Nationwide, random-sampled, and population-weighted telephone survey was conducted. The sample size of respondents was 1,000(age over 18). The respondents were asked about their use, out-of pocket expenditure of CAM in the past 12 months. SAS 8.0 statistic package was used for checking the relevance between each variables by performing $x^2-test$ and variance evaluation. Results : In 2001, 64.0% of people experienced more than one alternative therapy and the beneficiary took therapy average figure of 2.07. Alternative therapies were generally used for health promotion(73.7%) rather than curing the disease(26.3%). The most common therapies included Medication(30.2%), Physical-therapy(21.9%) health implements(20.8%), herb medication(19.2%), diet therapy(14.3%) etc. Average annual out-of-pocket expenditure was ￡<192,186. Use varied according to age, living province, income, and education, while cost expenditure did according to sex, health condition, income, education. Conclusions : The use of CAM in Korea is very large and the expenditure for them is 22.6% of national medical expenditure. It shows great need of political and academic approach.

• Research in Community and Public Health Nursing
• /
• v.17 no.2
• /
• pp.235-241
• /
• 2006

Purpose: This study was to review dysmenorrhea and its relief methods in nursing students by using base data for reducing dysmenorrhea. Method: The subjects were 92 students, data were collected by questionnaire surveys using convenience sampling and analyzed by the SPSS 12.0 program. Results: Medium amount of menstruation was most frequently answered and massage on painful sites was the most frequently used relief method(p<0.05). Frequency of medication was once a day during menstrual period, and methods that the most wanted to use when pain got severe was alternative methods(aroma, massage, and acupuncture)(p<0.05). Amount of menstruation showed a negative correlation with the duration(r=-0.32), dysmenorrhea was correlated with the severest days of dysmenorrhea(r=0.24) and the frequency of medication(r=-0.23). Conclusion: These results suggested that dysmenorrhea was correlated with the severest days of dysmenorrhea and the frequency of medication, but other variables showed no relations with menstrual characteristics.